FDA Inspection 1153089 — Reproductive Technologies, Inc.
The FDA completed an inspection of Reproductive Technologies, Inc. on Sep 13, 2021 in Berkeley, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Berkeley, CA (United States)